Latest Patient Square Capital LP Stock Portfolio
Patient Square Capital LP Performance:
2024 Q3: -1.87%YTD: -11.6%2023: -99.89%
Performance for 2024 Q3 is -1.87%, and YTD is -11.6%, and 2023 is -99.89%.
About Patient Square Capital LP and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Patient Square Capital LP reported an equity portfolio of $269.4 Millions as of 30 Sep, 2024.
The top stock holdings of Patient Square Capital LP are ROIV, LQDA, CGEM. The fund has invested 52.4% of it's portfolio in ROIVANT SCIENCES LTD and 26.7% of portfolio in LIQUIDIA CORPORATION.
Patient Square Capital LP opened new stock positions in CULLINAN THERAPEUTICS, INC. (CGEM), INSMED INC (INSM) and EYEPOINT PHARMACEUTICALS (EYPT).
The top stock holdings of Patient Square Capital LP are ROIV, LQDA, CGEM. The fund has invested 52.4% of it's portfolio in ROIVANT SCIENCES LTD and 26.7% of portfolio in LIQUIDIA CORPORATION.
Patient Square Capital LP opened new stock positions in CULLINAN THERAPEUTICS, INC. (CGEM), INSMED INC (INSM) and EYEPOINT PHARMACEUTICALS (EYPT).
Patient Square Capital LP Annual Return Estimates Vs S&P 500
Our best estimate is that Patient Square Capital LP made a return of -1.87% in the last quarter. In trailing 12 months, it's portfolio return was -14.37%.
New Buys
| Ticker | $ Bought |
|---|---|
| cullinan therapeutics, inc. | 13,805,600 |
| insmed inc | 12,534,400 |
| eyepoint pharmaceuticals | 10,882,200 |
| nurix therapeutics, inc. | 7,320,480 |
| pharvaris n.v. | 4,488,160 |
| intellia therapeutics, inc. | 2,642,090 |
| enliven therapeutics, inc. | 2,313,210 |
| ocular therapeutix, inc. | 2,048,830 |
New stocks bought by Patient Square Capital LP
Additions
Reductions
Sold off
Sector Distribution
Patient Square Capital LP has about 97.5% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 97.5 |
| Others | 2.5 |
Market Cap. Distribution
Patient Square Capital LP has about 4.7% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| MID-CAP | 53.4 |
| SMALL-CAP | 39.5 |
| LARGE-CAP | 4.7 |
| UNALLOCATED | 2.5 |
Stocks belong to which Index?
About 45.1% of the stocks held by Patient Square Capital LP either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 54.9 |
| RUSSELL 2000 | 45.1 |
Patient Square Capital LP Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Patient Square Capital LP
Patient Square Capital LP has 11 stocks in it's portfolio. LQDA proved to be the most loss making stock for the portfolio. ROIV was the most profitable stock for Patient Square Capital LP last quarter.
Last Reported on: 14 Nov, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ATXS | astria therapeutics, inc. | 0.16 | 39,422 | 434,036 | new | |||
| CGEM | cullinan therapeutics, inc. | 5.12 | 824,705 | 13,805,600 | new | |||
| EYPT | eyepoint pharmaceuticals | 4.04 | 1,361,980 | 10,882,200 | new | |||
| INSM | insmed inc | 4.65 | 171,704 | 12,534,400 | new | |||
| LQDA | liquidia corporation | 26.66 | 7,182,530 | 71,825,300 | unchanged | 0.00 | ||
| NRIX | nurix therapeutics, inc. | 2.72 | 325,789 | 7,320,480 | new | |||
| NTLA | intellia therapeutics, inc. | 0.98 | 128,569 | 2,642,090 | new | |||
| OCUL | ocular therapeutix, inc. | 0.76 | 235,498 | 2,048,830 | new | |||
| PHVS | pharvaris n.v. | 1.67 | 242,341 | 4,488,160 | new | |||
| ROIV | roivant sciences ltd | 52.38 | 12,228,500 | 141,116,000 | unchanged | 0.00 | ||
| enliven therapeutics, inc. | 0.86 | 90,572 | 2,313,210 | new | ||||